Light-Guided nanotech targets tough tumors
NCT ID NCT06599957
Summary
This study is developing a new way to deliver chemotherapy drugs to bone and soft tissue tumors using tiny nanoparticles and light. Researchers will test this approach on tumor samples from patients to see if it works better than standard chemotherapy. The goal is to gather strong evidence to support future clinical trials for people with hard-to-treat or inoperable sarcomas.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE AND SOFT TISSUE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori
RECRUITINGMeldola, Emilia-Romagna, 47014, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Istituto Ortopedico Rizzoli-OSOTT
RECRUITINGBologna, Emilia-Romagna, 40136, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.